It's difficult to summarize this study because it's packed with information but I'll do my best.
https://www.ncbi.nlm.nih.gov/pmc/articles/pmc10294829/General ideas:- They examined 10 cases of late tick-borne diseases.
- The mixed involvement part means the patients had different mixes of Borrelia, Babesia, Anaplasma, and Bartonella.
- The patients were treated with long-term antibiotic and antiparasitics, with treatment ranging between 13 to 60 months.
- All of them experienced complete remission of severe motor deficits, with a "Kurtzke disability score" of 0 two years after the end of the treatment protocol.
And the protocols were as follows:(please double check as I'm tired, copy and pasting most of it, and not proofreading)
Anti-Borrelia treatments:- Primary treatment consisting of a 35-day regimen of intravenous ceftriaxone 2 g/d with oral doxycycline 200 mg/d
- Followed by a 2–3-month oral regimen with doxycycline 200 mg/d-azithromycin 500 mg/d (DA) if possible
- In case of incomplete primary results or recurrence, patients had at least 2 supplementary 35-day intravenous ceftriaxone cycles with oral doxycycline 200 mg.
Anti-Babesia treatments:- Specific treatment using a 21-day regimen of atovaquone 1500 mg/d-azithromycin 500 mg/d (At-A) was administered in case of initial or secondary Babesia positivity
- It was repeated in the presence of symptoms evocative of Babesia.
Anti-Anaplasma and anti-Bartonella treatments:- Patients with a positive serology for Anaplasma phagocytophilum and/or Bartonella serology were treated using a 3-month oral regimen of doxycycline 200 mg/d-azithromycin and 500 mg/d-rifampicin 300 mg/d, repeated in case of failure.
Hope this helps a bit! Also I found this really nicely worded:
"Long-term protocols require great effort from patients and sustained monitoring by physicians. Their cost is also considerable and may multiply by 50 to 100 times the therapeutic financial investment when compared to habitual short treatments.
However, what price-tag can one put on the benefit of the return of an adult person to complete motor autonomy and to work? Moreover, on that of a teenager to normal life? These human advantages are enormous. The cured patients, after having experienced a long neurological nightmare, shared moving testimonies about
the dignity of their new life. Patient 8 returned to his supermarket director’s job after a 33-month interruption and decided to have a baby with his partner. The baby duly arrived."